Delivery Order SPE2DB22D2108-SPE2DB25FU2SM
Award Date
11/13/24
Potential Completion Date
11/14/24
Potential Value
$8.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTYP7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.49 firm fixed-price delivery order is for the supply of 4,566,566,063 units of the medication Glimepiride 4 mg tablets, with a completion date of November 29, 2024.
The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
The federal contract award with ID SPE2DB20D2104|SPE2DB25FMEXK was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,316.81, is for the delivery of 4 mg Glimepiride tablets in 100-count bottles. This is a firm fixed-price delivery order contract with a completion date of December 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $4,546.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of Glimepiride 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 6, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the...
This federal contract award, identified as SPE2DB20D3101|SPE2DB24FRVZ3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,620.54 firm fixed-price delivery order is for the supply of 4,565,926,029 tablets of the generic drug Glimepiride 4 mg. The contract has an ultimate completion date of September 25, 2024 and was awarded on September 24, 2024. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,564,571,235 Glimepiride 2 mg tablets in 100-count bottles. The $3,103.66 firm fixed-price delivery order has a completion date of May 13, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRQV3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,616.85 firm fixed-price delivery order is for the supply of 4565256438 - GLIMEPIRIDE 4 MG TABLET 100S, a generic pharmaceutical product. The contract has an ultimate completion date of July 26, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $4,046.78, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,931,294 units of Glimepiride 1 mg tablets in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,319.07 Firm Fixed Price Delivery Order covers the supply of 4,566,503,726 Glimepiride 2 mg tablets in 100 count bottles. The award has an ultimate completion date of November 21, 2024. This contract is not designated as a set-aside.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,121,745 Glimepiride 4 MG tablets in packages of 100. The $3,771.57 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) on July 11, 2024, with a completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,292.98 firm fixed-price delivery order is for Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...